Investing
Acquisitions
Over 2 years (FY 2021 to FY 2024), Acquisitions shows a downward trend with a -59.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
How to read this metric
High spending indicates an aggressive growth or diversification strategy, while low spending suggests a focus on organic growth or internal consolidation.
Detailed definition
This metric tracks the cash paid to acquire other businesses or business units, net of any cash acquired in the transact...
Peer comparison
Varies significantly based on M&A cycles; peers in the healthcare sector frequently use acquisitions to gain access to new diagnostic or therapeutic technologies.
Metric ID:
acquisitionsHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.00M | $94.00M | $17.88B | $40.00M | $2.70B | $47.00M | $909.00M | $0.00 | $0.00 | $0.00 | $3.13B | $0.00 | $0.00 | $8.87B |
| QoQ Change | — | +14.6% | >999% | -99.8% | >999% | -98.3% | >999% | -100.0% | — | — | — | -100.0% | — | — |
| YoY Change | — | — | — | — | >999% | — | — | — | -100.0% | -100.0% | +244.6% | — | — | — |
Range$0.00 – $17.88B
CAGR+322.6%
Avg YoY Growth>999%
Median YoY Growth+72.3%
Acquisitions at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's acquisitions?
- Thermo Fisher Scientific (TMO) reported acquisitions of $8.87B in Q1 2026.
- What is the long-term trend for Thermo Fisher Scientific's acquisitions?
- Over 2 years (2021 to 2024), Thermo Fisher Scientific's acquisitions has grown at a -59.8% compound annual growth rate (CAGR), from $19.40B to $3.13B.
- What does acquisitions mean?
- Cash spent to buy other companies or business units.